FXL17_XENLA
ID FXL17_XENLA Reviewed; 673 AA.
AC B1H1X1; A0A1L8I1L2;
DT 07-NOV-2018, integrated into UniProtKB/Swiss-Prot.
DT 29-APR-2008, sequence version 1.
DT 03-AUG-2022, entry version 54.
DE RecName: Full=F-box/LRR-repeat protein 17 {ECO:0000303|PubMed:30190310};
DE AltName: Full=F-box and leucine-rich repeat protein 17 {ECO:0000305};
GN Name=fbxl17 {ECO:0000303|PubMed:30190310,
GN ECO:0000312|Xenbase:XB-GENE-4755769};
OS Xenopus laevis (African clawed frog).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Amphibia;
OC Batrachia; Anura; Pipoidea; Pipidae; Xenopodinae; Xenopus; Xenopus.
OX NCBI_TaxID=8355;
RN [1]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC STRAIN=J;
RX PubMed=27762356; DOI=10.1038/nature19840;
RA Session A.M., Uno Y., Kwon T., Chapman J.A., Toyoda A., Takahashi S.,
RA Fukui A., Hikosaka A., Suzuki A., Kondo M., van Heeringen S.J., Quigley I.,
RA Heinz S., Ogino H., Ochi H., Hellsten U., Lyons J.B., Simakov O.,
RA Putnam N., Stites J., Kuroki Y., Tanaka T., Michiue T., Watanabe M.,
RA Bogdanovic O., Lister R., Georgiou G., Paranjpe S.S., van Kruijsbergen I.,
RA Shu S., Carlson J., Kinoshita T., Ohta Y., Mawaribuchi S., Jenkins J.,
RA Grimwood J., Schmutz J., Mitros T., Mozaffari S.V., Suzuki Y., Haramoto Y.,
RA Yamamoto T.S., Takagi C., Heald R., Miller K., Haudenschild C., Kitzman J.,
RA Nakayama T., Izutsu Y., Robert J., Fortriede J., Burns K., Lotay V.,
RA Karimi K., Yasuoka Y., Dichmann D.S., Flajnik M.F., Houston D.W.,
RA Shendure J., DuPasquier L., Vize P.D., Zorn A.M., Ito M., Marcotte E.M.,
RA Wallingford J.B., Ito Y., Asashima M., Ueno N., Matsuda Y., Veenstra G.J.,
RA Fujiyama A., Harland R.M., Taira M., Rokhsar D.S.;
RT "Genome evolution in the allotetraploid frog Xenopus laevis.";
RL Nature 538:336-343(2016).
RN [2]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC TISSUE=Embryo;
RG NIH - Xenopus Gene Collection (XGC) project;
RL Submitted (MAR-2008) to the EMBL/GenBank/DDBJ databases.
RN [3]
RP FUNCTION, TISSUE SPECIFICITY, AND DISRUPTION PHENOTYPE.
RX PubMed=30190310; DOI=10.1126/science.aap8236;
RA Mena E.L., Kjolby R.A.S., Saxton R.A., Werner A., Lew B.G., Boyle J.M.,
RA Harland R., Rape M.;
RT "Dimerization quality control ensures neuronal development and survival.";
RL Science 362:eaap8236-eaap8236(2018).
CC -!- FUNCTION: Substrate-recognition component of the SCF(FBXL17) E3
CC ubiquitin ligase complex, a key component of a quality control pathway
CC required to ensure functional dimerization of BTB domain-containing
CC proteins (dimerization quality control, DQC) (PubMed:30190310). FBXL17
CC specifically recognizes and binds a conserved degron of non-consecutive
CC residues present at the interface of BTB dimers of aberrant
CC composition: aberrant BTB dimer are then ubiquitinated by the
CC SCF(FBXL17) complex and degraded by the proteasome (By similarity). The
CC ability of the SCF(FBXL17) complex to eliminate compromised BTB dimers
CC is required for the differentiation and survival of neural crest and
CC neuronal cells (PubMed:30190310). {ECO:0000250|UniProtKB:Q9UF56,
CC ECO:0000269|PubMed:30190310}.
CC -!- SUBUNIT: Part of the SCF (SKP1-CUL1-F-box) E3 ubiquitin-protein ligase
CC complex SCF(FBXL17). Interacts with BTB domain-containing proteins;
CC specifically recognizes and binds a conserved degron of non-consecutive
CC residues present at the interface of BTB dimers of aberrant
CC composition. {ECO:0000250|UniProtKB:Q9UF56}.
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q9UF56}. Nucleus
CC {ECO:0000250|UniProtKB:Q9UF56}. Note=Present in the cytoplasm and
CC nucleus; more abundant in the cytoplasm.
CC {ECO:0000250|UniProtKB:Q9UF56}.
CC -!- TISSUE SPECIFICITY: Expressed in the neuro-ectoderm of embryos.
CC {ECO:0000269|PubMed:30190310}.
CC -!- DISRUPTION PHENOTYPE: Impaired nervous system development caused by
CC inability to eliminate aberrant BTB domain-containing protein dimers.
CC {ECO:0000269|PubMed:30190310}.
CC -!- SIMILARITY: Belongs to the FBXL17 family. {ECO:0000305}.
CC -!- SEQUENCE CAUTION:
CC Sequence=OCU02262.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; CM004466; OCU02262.1; ALT_SEQ; Genomic_DNA.
DR EMBL; BC160768; AAI60768.1; -; mRNA.
DR RefSeq; NP_001121244.1; NM_001127772.1.
DR AlphaFoldDB; B1H1X1; -.
DR SMR; B1H1X1; -.
DR STRING; 8355.B1H1X1; -.
DR GeneID; 100158323; -.
DR KEGG; xla:100158323; -.
DR CTD; 100158323; -.
DR Xenbase; XB-GENE-4755769; fbxl17.L.
DR OrthoDB; 524674at2759; -.
DR Proteomes; UP000186698; Chromosome 1L.
DR Bgee; 100158323; Expressed in testis and 19 other tissues.
DR GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR GO; GO:0019005; C:SCF ubiquitin ligase complex; ISS:UniProtKB.
DR GO; GO:0007399; P:nervous system development; IMP:UniProtKB.
DR GO; GO:0014033; P:neural crest cell differentiation; IMP:UniProtKB.
DR GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; ISS:UniProtKB.
DR GO; GO:0000209; P:protein polyubiquitination; ISS:UniProtKB.
DR GO; GO:0006515; P:protein quality control for misfolded or incompletely synthesized proteins; ISS:UniProtKB.
DR GO; GO:0016567; P:protein ubiquitination; ISS:UniProtKB.
DR GO; GO:0008589; P:regulation of smoothened signaling pathway; ISS:UniProtKB.
DR GO; GO:0031146; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; ISS:UniProtKB.
DR Gene3D; 3.80.10.10; -; 2.
DR InterPro; IPR036047; F-box-like_dom_sf.
DR InterPro; IPR001810; F-box_dom.
DR InterPro; IPR001611; Leu-rich_rpt.
DR InterPro; IPR006553; Leu-rich_rpt_Cys-con_subtyp.
DR InterPro; IPR032675; LRR_dom_sf.
DR Pfam; PF12937; F-box-like; 1.
DR Pfam; PF13516; LRR_6; 1.
DR SMART; SM00256; FBOX; 1.
DR SMART; SM00367; LRR_CC; 11.
DR SUPFAM; SSF81383; SSF81383; 1.
DR PROSITE; PS50181; FBOX; 1.
PE 2: Evidence at transcript level;
KW Cytoplasm; Neurogenesis; Nucleus; Reference proteome;
KW Ubl conjugation pathway.
FT CHAIN 1..673
FT /note="F-box/LRR-repeat protein 17"
FT /id="PRO_0000445655"
FT DOMAIN 291..338
FT /note="F-box"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00080"
FT REGION 1..39
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 1..38
FT /note="Basic and acidic residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ SEQUENCE 673 AA; 73081 MW; 496B8ACF210F4EA8 CRC64;
MGHVAPHASK KEHVAPHAAE KDHVAPHASK KEHVAPHAAE KGQVAPYAAG EGQVAPNAAG
ERPVAPYAAG EGQVAPYAAG EGQVAPYAAG EGQVAPYAAG EGQVAPYAAG EAQVAPHAAG
EGRVAPHAAG DGQVEHCTVE DREEGHIGTT EQGHMSHYTS KLEHMAPPSA QTEAVVSYVA
GERHAPPDCT VSGPAMCCSA EARQTTPDWT TTGPEISQGT LPGLTVLHVG GTWQTFAAED
EPCVTTLLSP VKPLSSSRKY APYNLQIPSY SESEPQAHKG LSSETFGPCE PLHINQLPSS
LLLKIFSNLS LNERCILASL VCKYWRDLCL DSQFWKQLDL SNRQQIKDNI LEEIASRSQN
ITEINISDCF SVSDQGVCVV ALKCPGLVKY TAYRCKQLSD ISLIALAAHC PSLQKVHVGN
QDKLSDEALI QMGRRCKELK DIHFGQCYKI SDEGLIVIAK GCQKLQKIYM QENKLVSDES
VKAFAEHCPG LQYVGFMGCS VTSEGVINLT KLKHLSSLDL RHITELDNET VMEIVKQCQH
LTSLNLCLNR SINDRCVEVI AKEGRSLKEL YLVTCKITDY ALIAIGRYSK SIETVDVGWC
KEITDYGAKQ IAQSSKSIRY LGLMRCDKVN EATVEQLVQQ YPHITFSTVL QDCKRTLERA
YQMGWTPNAS PAT